COVID-19 Pandemic Emphasized the Importance of In Vitro Diagnostics, More than $127 Billion Worth Market Opportunity in the IVD Market - Arizton

According to Arizton's latest research report, the in-vitro diagnostics market will grow at a CAGR of 3.3% from 2022-2028. In recent years, IVD diagnostics has been one of the biggest industries that observed several product launches. The increasing demand for new diagnostics tests forced the development of new solutions. Currently, the IVD players are operating in a world that designs, develops, manufactures, and sells best-in-class solutions. COVID-19 is one of the best periods where several companies have come forward to develop rapid test kits to detect coronavirus. The leading market players are competing with rapidly emerging players in the market. Vendors in the market are increasing their share through inorganic growth. There is a constant product launch, helping the vendors acquire new customers in the market.
In 2022, North America accounted for the largest share of 40% of the global IVD market. The patient population with high healthcare expenditure is the major factor driving the in-vitro diagnostics market across North America. In addition, awareness about disease diagnosis, such as point-of-care, early detection, and preventive health check-ups, are some factors that positively impact the region's market growth. More than 60% to 80% of the regional population have any chronic condition, which led to demand for diagnostics services. The expenditure for healthcare services in the region is more than $3 trillion, indicating the potential growth of in-vitro diagnostics in the region. Moreover, the presence of market players and their market penetration in the region fuel access to IVD services.
The POC diagnostics market is growing faster than the traditional IVD industry. Over the few years, there has been a constant increase in the number of approved POC devices. In Canada's healthcare services, one of the emerging factors is point-of-care which is expected to drive the market in the future. The Canadian Standard Association has developed requirements that apply to POC (CAN.CSA-Z22870-07). The demand for POC for infectious diseases is increasing and becoming an important part of healthcare systems. In cancer and infectious disease diagnosis, point-of-care IVD solutions are commonly used.

If our report does not include the information you are searching for, you may contact us to have a report tailored to your specific business needs https://www.arizton.com/customize-report/3703

REAGENT & CONSUMABLES MARKET TO BOOM THE ADOPTION RATE OF IN-VITRO DIAGNOSTICS MARKET
Faster adoption of concentrated reagents has enhanced vendors' competitiveness by improving customer satisfaction and reducing CO2 emissions and waste by decreasing the number of reagent shipments.
The global in-vitro diagnostics market by reagents & consumables has been growing rapidly in recent years. The COVID-19 pandemic has significantly boosted demand for reagents used in IVD procedures to run the COVID-19 sample for diagnosis. With the increasing demand for disease diagnosis and the rising number of clinical and research laboratories, the demand for IVD reagents is significantly increasing.
Innovation in consumables, especially reagents, is low compared to analyzers. Some companies do come up with new types of reagents for unique products. For instance, Sysmex, a Japanese company, developed a concentrated reagent for hematology analyzers. These concentrated reagents are gaining traction in the market, especially in developed countries. This is helping the company to gain market share.

Click Here to Download the Free Sample Report: https://www.arizton.com/request-sample/3703

COVID-19 PANDEMIC POSITIVELY IMPACTING THE MARKET GROWTH
In the global IVD market, manufacturers played a vital role in enabling countries to broaden their COVID-19 testing capacity- certainly, molecular testing instruments usually dedicated to tuberculosis and HIV programs constitute major opportunities to be repurposed for COVID-19 response.
The COVID-19 pandemic has highlighted the importance of IVD solutions. According to "under Emergency Use Authorization" in the US and "under the in-vitro Diagnostics Directive" (IVDD) in Europe, the preference for self-testing solutions increased significantly, thus driving the market growth through rapid COVID-19 test kits. Several COVID-19 self-test kits were developed to drive the companies' revenue growth.
KEY COMPANY PROFILES
• Abbott
• Danaher
• F. Hoffmann-La Roche
• Siemens Healthineers
• Thermo Fisher Scientific
• Atomo Diagnostics
• Accelerate Diagnostics
• Agilent Technologies
• altona Diagnostics
• Amoy Diagnostics
• ARKRAY
• AccuBioTech
• Agappe Diagnostics
• BD
• Bio-Rad Laboratories
• Balio diagnostics
• B&E BIO-TECHNOLOGY
• BIOMÉRIEUX
• bioLytical Laboratories
• Biosynex
• Biocartis
• Biocept
• Biohit Oyj
• Biomerica
• Biosystems
• Bioway Biological Technology
• Boule Diagnostics
• Cupid Limited
• CareDx
• Chembio Diagnostics
• CLINDIAG SYSTEMS
• CONTEC MEDICAL SYSTEMS
• Convergent Technologies
• CPC Diagnostics
• CPM Scientifica
• CellaVision
• DIALAB
• Dexcom
• DiaSorin
• Diagon
• Diatron
• DIRUI
• Drucker Diagnostics
• EDAN Instruments
• EKF Diagnostics Holdings
• ELITechGroup
• Erba Diagnostics
• Genetron Holdings
• Genrui Biotech
• Hologic
• High Technology
• HORIBA
• Linear Chemicals
• Illumina
• INTEC
• J. Mitra & Co.
• Kilpest India Limited
• Maccura Biotechnology
• Medsource Ozone Biomedicals
• Meril Life Sciences
• MP Biomedicals
• Nanjing Synthgene Medical Technology
• NIHON KOHDEN
• Norma Instruments
• NOWDiagnostics
• Ortho Clinical Diagnostics
• OPKO Health
• OraSure Technologies
• Perkin Elmer
• Prestige Diagnostics
• QIAGEN
• Quidel
• Sysmex
• Salofa Oy
• SEASUN BIOMATERIALS
• Sekisui Diagnostics
• SFRI
• Shenzhen Dymind Biotechnology
• Shenzhen iCubio Biomedical Technology
• Shenzhen Mindray Bio-Medical Electronics
• SHENZHEN PROKAN ELECTRONICS
• Shenzhen Landwind Medical
• Sinocare
• SPINREACT
• SureScreen Diagnostics
• The Binding Site Group
• Trinity Biotech
• Trivitron Healthcare
• Xiamen Biotime Biotechnology
• Zhejiang Orient Gene Biotech
MARKET SEGMENTATION
Product & Services
• Reagents and Consumables
• Instruments/ Analyzers & Software
• Services
Technology
• Immuno and Clinical Chemistry
• Molecular Diagnostics
• Hematology
• Microbiology and Cytology
• Others Technology
Application
• Infectious Diseases
• Diabetes
• Cardiology
• Oncology
• Autoimmune Diseases
• Nephrology
• Drug Testing
• Others
End-Users
• Standard Reference Labs
• Hospital-Affiliated Labs
• Individuals
• Clinics
• Others
Geography
• North America
o US
o Canada
• Europe
o Germany
o France
o Russia
o Spain
o Italy
o UK
• APAC
o China
o Japan
o India
o South Korea
o Australia
o Indonesia
o Malaysia
o Singapore
• Latin America
o Brazil
o Mexico
o Argentina
• Middle East & Africa
o Turkey
o Saudi Arabia
o South Africa

Know more about the market: https://www.arizton.com/market-reports/in-vitro-diagnostics-market

TABLE OF CONTENT
1 RESEARCH METHODOLOGY
2 RESEARCH OBJECTIVES
3 RESEARCH PROCESS
4 SCOPE & COVERAGE
4.1 MARKET DEFINITION
4.1.1 INCLUSIONS
4.1.2 EXCLUSIONS
4.1.3 MARKET ESTIMATION CAVEATS
4.2 BASE YEAR
4.3 SCOPE OF THE STUDY
4.3.1 MARKET BY PRODUCT & SERVICES:
4.3.2 MARKET BY TECHNOLOGY
4.3.3 MARKET BY APPLICATION
4.3.4 MARKET BY END-USERS
4.3.5 MARKET SEGMENTATION BY GEOGRAPHY
5 REPORT ASSUMPTIONS & CAVEATS
5.1 KEY CAVEATS
5.2 CURRENCY CONVERSION
5.3 MARKET DERIVATION
6 MARKET AT A GLANCE
7 PREMIUM INSIGHTS
7.1 OVERVIEW
8 INTRODUCTION
8.1 OVERVIEW
9 MARKET OPPORTUNITIES & TRENDS
9.1 ADVANCES IN MOLECULAR DIAGNOSTICS TRANSFORMING THE FUTURE OF HEALTHCARE
9.2 INCREASED DEMAND FOR COMPANION DIAGNOSTICS IN IVD
9.3 INCREASING PRODUCT LAUNCHES & MERGERS & ACQUISITIONS IN IVD
10 MARKET GROWTH ENABLERS
10.1 PRESENCE OF A SIGNIFICANT PATIENT POPULATION
10.2 ADOPTION OF ADVANCED TECHNOLOGIES IN IVD
10.3 COVID-19 IMPACT ON IVD MARKET
11 MARKET RESTRAINTS
11.1 STRINGENT REGULATIONS AND ASSOCIATED CHALLENGES
11.2 HIGH COST OF IVD
11.3 LACK OF ACCESS TO DIAGNOSTIC SERVICES AND ASSOCIATED CHALLENGES
12 MARKET LANDSCAPE
12.1 MARKET OVERVIEW
12.1.1 INSIGHT BY PRODUCT & SERVICES
12.1.2 INSIGHT BY TECHNOLOGY
12.1.3 INSIGHT BY APPLICATION
12.1.4 INSIGHT BY END-USERS
12.1.5 INSIGHT BY GEOGRAPHY
12.2 MARKET SIZE & FORECAST
12.3 FIVE FORCES ANALYSIS
12.3.1 THREAT OF NEW ENTRANTS
12.3.2 BARGAINING POWER OF SUPPLIERS
12.3.3 BARGAINING POWER OF BUYERS
12.3.4 THREAT OF SUBSTITUTES
12.3.5 COMPETITIVE RIVALRY
13 PRODUCT & SERVICES
13.1 MARKET SNAPSHOT & GROWTH ENGINE
13.2 MARKET OVERVIEW
13.3 REAGENTS AND CONSUMABLES
13.3.1 MARKET OVERVIEW
13.3.2 MARKET SIZE & FORECAST
13.3.3 MARKET BY GEOGRAPHY
13.4 INSTRUMENTS/ANALYZERS & SOFTWARE
13.4.1 MARKET OVERVIEW
13.4.2 MARKET SIZE & FORECAST
13.4.3 MARKET BY GEOGRAPHY
13.5 SERVICES
13.5.1 MARKET OVERVIEW
13.5.2 MARKET SIZE & FORECAST
13.5.3 MARKET BY GEOGRAPHY
14 TECHNOLOGY
14.1 MARKET SNAPSHOT & GROWTH ENGINE
14.2 MARKET OVERVIEW
14.3 IMMUNO & CLINICAL CHEMISTRY
14.3.1 MARKET OVERVIEW
14.3.2 MARKET SIZE & FORECAST
14.3.3 MARKET BY GEOGRAPHY
14.4 MOLECULAR DIAGNOSTICS
14.4.1 MARKET OVERVIEW
14.4.2 MARKET SIZE & FORECAST
14.4.3 MARKET BY GEOGRAPHY
14.5 HEMATOLOGY
14.5.1 MARKET OVERVIEW
14.5.2 MARKET SIZE & FORECAST
14.5.3 MARKET BY GEOGRAPHY
14.6 MICROBIOLOGY & CYTOLOGY
14.6.1 MARKET OVERVIEW
14.6.2 MARKET SIZE & FORECAST
14.6.3 MARKET BY GEOGRAPHY
14.7 OTHERS
14.7.1 MARKET OVERVIEW
14.7.2 MARKET SIZE & FORECAST
14.7.3 MARKET BY GEOGRAPHY
15 APPLICATION
15.1 MARKET SNAPSHOT & GROWTH ENGINE
15.2 MARKET OVERVIEW
15.3 INFECTIOUS DISEASES
15.3.1 MARKET OVERVIEW
15.3.2 MARKET SIZE & FORECAST
15.3.3 MARKET BY GEOGRAPHY
15.4 DIABETES
15.4.1 MARKET OVERVIEW
15.4.2 MARKET SIZE & FORECAST
15.4.3 MARKET BY GEOGRAPHY
15.5 CARDIOLOGY
15.5.1 MARKET OVERVIEW
15.5.2 MARKET SIZE & FORECAST
15.5.3 MARKET BY GEOGRAPHY
15.6 ONCOLOGY
15.6.1 MARKET OVERVIEW
15.6.2 MARKET SIZE & FORECAST
15.6.3 MARKET BY GEOGRAPHY
15.7 AUTOIMMUNE DISEASE
15.7.1 MARKET OVERVIEW
15.7.2 MARKET SIZE & FORECAST
15.7.3 MARKET BY GEOGRAPHY
15.8 NEPHROLOGY
15.8.1 MARKET OVERVIEW
15.8.2 MARKET SIZE & FORECAST
15.8.3 MARKET BY GEOGRAPHY
15.9 DRUG TESTING
15.9.1 MARKET OVERVIEW
15.9.2 MARKET SIZE & FORECAST
15.9.3 MARKET BY GEOGRAPHY
15.10 OTHERS
15.10.1 MARKET OVERVIEW
15.10.2 MARKET SIZE & FORECAST
15.10.3 MARKET BY GEOGRAPHY
16 END-USERS
16.1 MARKET SNAPSHOT & GROWTH ENGINE
16.2 MARKET OVERVIEW
16.3 STANDARD REFERENCE LABS
16.3.1 MARKET OVERVIEW
16.3.2 MARKET SIZE & FORECAST
16.3.3 MARKET BY GEOGRAPHY
16.4 HOSPITAL-AFFILIATED LABS
16.4.1 MARKET OVERVIEW
16.4.2 MARKET SIZE & FORECAST
16.4.3 MARKET BY GEOGRAPHY
16.5 INDIVIDUALS
16.5.1 MARKET OVERVIEW
16.5.2 MARKET SIZE & FORECAST
16.5.3 MARKET BY GEOGRAPHY
16.6 CLINICS
16.6.1 MARKET OVERVIEW
16.6.2 MARKET SIZE & FORECAST
16.6.3 MARKET BY GEOGRAPHY
16.7 OTHERS
16.7.1 MARKET OVERVIEW
16.7.2 MARKET SIZE & FORECAST
16.7.3 MARKET BY GEOGRAPHY
17 GEOGRAPHY
17.1 MARKET SNAPSHOT & GROWTH ENGINE
17.2 GEOGRAPHIC OVERVIEW
18 NORTH AMERICA
18.1 MARKET OVERVIEW
18.2 MARKET SIZE & FORECAST
18.3 PRODUCT & SERVICES
18.3.1 MARKET SIZE & FORECAST
18.4 TECHNOLOGY
18.4.1 MARKET SIZE & FORECAST
18.5 APPLICATION
18.5.1 MARKET SIZE & FORECAST
18.6 END-USER
18.6.1 MARKET SIZE & FORECAST
18.7 KEY COUNTRIES
18.7.1 US: MARKET SIZE & FORECAST
18.7.2 CANADA: MARKET SIZE & FORECAST
19 EUROPE
19.1 MARKET OVERVIEW
19.2 MARKET SIZE & FORECAST
19.3 PRODUCT & SERVICES
19.3.1 MARKET SIZE & FORECAST
19.4 TECHNOLOGY
19.4.1 MARKET SIZE & FORECAST
19.5 APPLICATION
19.5.1 MARKET SIZE & FORECAST
19.6 END-USER
19.6.1 MARKET SIZE & FORECAST
19.7 KEY COUNTRIES
19.7.1 GERMANY: MARKET SIZE & FORECAST
19.7.2 FRANCE: MARKET SIZE & FORECAST
19.7.3 RUSSIA: MARKET SIZE & FORECAST
19.7.4 SPAIN: MARKET SIZE & FORECAST
19.7.5 ITALY: MARKET SIZE & FORECAST
19.7.6 UK: MARKET SIZE & FORECAST
20 APAC
20.1 MARKET OVERVIEW
20.2 MARKET SIZE & FORECAST
20.3 PRODUCT & SERVICES
20.3.1 MARKET SIZE & FORECAST
20.4 TECHNOLOGY
20.4.1 MARKET SIZE & FORECAST
20.5 APPLICATION
20.5.1 MARKET SIZE & FORECAST
20.6 END-USER
20.6.1 MARKET SIZE & FORECAST
20.7 KEY COUNTRIES
20.7.1 CHINA: MARKET SIZE & FORECAST
20.7.2 JAPAN: MARKET SIZE & FORECAST
20.7.3 INDIA: MARKET SIZE & FORECAST
20.7.4 SOUTH KOREA: MARKET SIZE & FORECAST
20.7.5 AUSTRALIA: MARKET SIZE & FORECAST
20.7.6 INDONESIA: MARKET SIZE & FORECAST
20.7.7 MALAYSIA MARKET SIZE & FORECAST
20.7.8 SINGAPORE MARKET SIZE & FORECAST
21 LATIN AMERICA
21.1 MARKET OVERVIEW
21.2 MARKET SIZE & FORECAST
21.3 PRODUCT & SERVICES
21.3.1 MARKET SIZE & FORECAST
21.4 TECHNOLOGY
21.4.1 MARKET SIZE & FORECAST
21.5 APPLICATION
21.5.1 MARKET SIZE & FORECAST
21.6 END-USER
21.6.1 MARKET SIZE & FORECAST
21.7 KEY COUNTRIES
21.7.1 BRAZIL: MARKET SIZE & FORECAST
21.7.2 MEXICO: MARKET SIZE & FORECAST
21.7.3 ARGENTINA: MARKET SIZE & FORECAST
22 MIDDLE EAST & AFRICA
22.1 MARKET OVERVIEW
22.2 MARKET SIZE & FORECAST
22.3 PRODUCT & SERVICES
22.3.1 MARKET SIZE & FORECAST
22.4 TECHNOLOGY
22.4.1 MARKET SIZE & FORECAST
22.5 APPLICATION
22.5.1 MARKET SIZE & FORECAST
22.6 END-USER
22.6.1 MARKET SIZE & FORECAST
22.7 KEY COUNTRIES
22.7.1 TURKEY: MARKET SIZE & FORECAST
22.7.2 SAUDI ARABIA: MARKET SIZE & FORECAST
22.7.3 SOUTH AFRICA: MARKET SIZE & FORECAST
23 COMPETITIVE LANDSCAPE
23.1 COMPETITION OVERVIEW
23.2 MARKET SHARE ANALYSIS
23.2.1 ABBOTT
23.2.2 DANAHER
23.2.3 F. HOFFMANN-LA ROCHE
23.2.4 SIEMENS HEALTHINEERS
23.2.5 THERMO FISHER SCIENTIFIC
24 KEY COMPANY PROFILES
24.1 ABBOTT
24.1.1 BUSINESS OVERVIEW
24.1.2 PRODUCT OFFERINGS
24.1.3 KEY STRATEGIES
24.1.4 KEY STRENGTHS
24.1.5 KEY OPPORTUNITIES
24.2 DANAHER
24.3 F. HOFFMANN-LA ROCHE
24.4 SIEMENS HEALTHINEERS
24.5 THERMO FISHER SCIENTIFIC
25 OTHER PROMINENT VENDORS
25.1 ATOMO DIAGNOSTICS
25.1.1 BUSINESS OVERVIEW
25.1.2 PRODUCT OFFERINGS
25.2 ACCELERATE DIAGNOSTICS
25.3 AGILENT TECHNOLOGIES
25.4 ALTONA DIAGNOSTICS
25.5 AMOY DIAGNOSTICS
25.6 ARKRAY
25.7 ACCUBIOTECH
25.8 AGAPPE DIAGNOSTICS
25.9 BD
25.10 BIO-RAD LABORATORIES
25.11 BALIO DIAGNOSTICS
25.12 B&E BIO-TECHNOLOGY
25.13 BIOMÉRIEUX
25.14 BIOLYTICAL LABORATORIES
25.15 BIOSYNEX
25.16 BIOCARTIS
25.17 BIOCEPT
25.18 BIOHIT OYJ
25.19 BIOMERICA
25.20 BIOSYSTEM
25.21 BIOWAY BIOLOGICAL TECHNOLOGY
25.22 BOULE DIAGNOSTICS
25.23 CUPID LIMITED
25.24 CAREDX
25.25 CHEMBIO DIAGNOSTICS
25.26 CLINDIAG SYSTEMSA
25.27 CONTEC MEDICAL SYSTEMS
25.28 CONVERGENT TECHNOLOGIES
25.29 CPC DIAGNOSTICS
25.30 CPM SCIENTIFICA
25.31 CELLAVISION
25.32 DIALAB
25.33 DEXCOM
25.34 DIASORIN
25.35 DIAGON
25.36 DIATRON
25.37 DIRUI
25.38 DRUCKER DIAGNOSTICS
25.39 EDAN INSTRUMENTS
25.40 EKF DIAGNOSTICS HOLDING
25.41 ELITECHGROUP
25.42 ERBA DIAGNOSTICS
25.43 GENETRON HOLDINGS
25.44 GENRUI BIOTECH
25.45 HOLOGIC
25.46 HIGH TECHNOLOGY
25.47 HORIBA
25.48 LINEAR CHEMICALS
25.49 ILLUMINA
25.50 INTEC
25.51 J. MITRA & CO.
25.52 KILPEST INDIA LIMITED
25.53 MACCURA BIOTECHNOLOGY
25.54 MEDSOURCE OZONE BIOMEDICALS
25.55 MERIL LIFE SCIENCES
25.56 MP BIOMEDICALS
25.57 NANJING SYNTHGENE MEDICAL TECHNOLOGY
25.58 NIHON KOHDEN
25.59 NORMA INSTRUMENTS
25.60NOWDIAGNOSTICS
25.61 ORTHO CLINICAL DIAGNOSTICS
25.62 OPKO HEALTH (BIOREFERENCE HEALTH)
25.63 ORASURE TECHNOLOGIES
25.64 PERKIN ELMER
25.65 PRESTIGE DIAGNOSTICS
25.66 QIAGEN
25.67 QUIDEL
25.68 SYSMEX
25.69 SALOFA OY
25.70 SEASUN BIOMATERIALS
25.71 SEKISUI DIAGNOSTICS
25.72 SFRI
25.73 SHENZHEN DYMIND BIOTECHNOLOGY
25.74 SHENZHEN ICUBIO BIOMEDICAL TECHNOLOGY
25.75 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS
25.76 SHENZHEN PROKAN ELECTRONICS
25.77 SHENZHEN LANDWIND MEDICAL
25.78 SINOCARE
25.79 SPINREACT
25.80 SURESCREEN DIAGNOSTICS
25.81 THE BINDING SITE GROUP
25.82 TRINITY BIOTECH
25.83 TRIVITRON HEALTHCARE
25.84 XIAMEN BIOTIME BIOTECHNOLOGY
25.85 ZHEJIANG ORIENT GENE BIOTECH
26 REPORT SUMMARY
26.1 KEY TAKEAWAYS
26.2 STRATEGIC RECOMMENDATIONS
27 QUANTITATIVE SUMMARY
27.1 MARKET BY GEOGRAPHY
27.2 MARKET BY PRODUCT & SERVICES
27.3 MARKET BY TECHNOLOGY
27.4 MARKET BY APPLICATION
27.5 MARKET BY END-USERS
27.6 PRODUCT & SERVICES: MARKET BY GEOGRAPHY
27.6.1 REAGENTS & CONSUMABLES: MARKET BY GEOGRAPHY
27.6.2 INSTRUMENTS/ANALYZERS & SOFTWARE: MARKET BY GEOGRAPHY
27.6.3 SERVICES: MARKET BY GEOGRAPHY
27.7 TECHNOLOGY: MARKET BY GEOGRAPHY
27.7.1 IMMUNO & CLINICAL CHEMISTRY: MARKET BY GEOGRAPHY
27.7.2 MOLECULAR DIAGNOSTICS: MARKET BY GEOGRAPHY
27.7.3 HEMATOLOGY: MARKET BY GEOGRAPHY
27.7.4 MICROBIOLOGY & CYTOLOGY: MARKET BY GEOGRAPHY
27.7.5 OTHER TECHNOLOGIES: MARKET BY GEOGRAPHY
27.8 APPLICATION: MARKET BY GEOGRAPHY
27.8.1 INFECTIOUS DISEASES: MARKET BY GEOGRAPHY
27.8.2 DIABETES: MARKET BY GEOGRAPHY
27.8.3 CARDIOLOGY: MARKET BY GEOGRAPHY
27.8.4 ONCOLOGY: MARKET BY GEOGRAPHY
27.8.5 AUTOIMMUNE DISEASES: MARKET BY GEOGRAPHY
27.8.6 NEPHROLOGY: MARKET BY GEOGRAPHY
27.8.7 DRUG TESTING: MARKET BY GEOGRAPHY
27.8.8 OTHER APPLICATIONS: MARKET BY GEOGRAPHY
27.9 END-USERS: MARKET BY GEOGRAPHY
27.9.1 STANDARD REFERENCE LABS: MARKET BY GEOGRAPHY
27.9.2 HOSPITAL AFFILIATED LABS: MARKET BY GEOGRAPHY
27.9.3 INDIVIDUALS: MARKET BY GEOGRAPHY
27.9.4 CLINICS: MARKET BY GEOGRAPHY
27.9.5 OTHER END-USERS: MARKET BY GEOGRAPHY
28 APPENDIX
28.1 ABBREVIATIONS

ABOUT US:
Arizton Advisory and Intelligence is an innovative and quality-driven firm that offers cutting-edge research solutions to clients worldwide. We excel in providing comprehensive market intelligence reports and advisory and consulting services.
We offer comprehensive market research reports on consumer goods & retail technology, automotive and mobility, smart tech, healthcare, life sciences, industrial machinery, chemicals, materials, I.T. and media, logistics, and packaging. These reports contain detailed industry analysis, market size, share, growth drivers, and trend forecasts. 
Arizton comprises a team of exuberant and well-experienced analysts who have mastered generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports. 

Call: +1-312-235-2040 
          +1 302 469 0707 
Mail: enquiry@arizton.com

This release was published on openPR.